Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Phentermine
Drug ID BADD_D01756
Description Phentermine is a sympathomimetic amine anorectic agent and it was introduced in 1959 as part of an anti-obesity combination drug.[A174361, A174364] It is chemically related to amphetamine and it is commonly referred to as an atypical amphetamine.[A174370] Phentermine has not been reported an addictive potential which allows this agent to be classified under the Schedule IV drugs (low abuse potential).[A174367] Phentermine was FDA approved for short-term weight management in 1959 and it became widely used in 1960. This initial product, formed by the combination of phentermine with [fenfluramine] and [dexfenfluramine] was discontinued after finding several reports of abnormal valves in nearly 30% of the consumers.[A174376, T403] Later on, phentermine was approved alone and in combination with topiramate in 2012 as a new alternative that required lower doses of phentermine to obtain the desired effect.[A174373]
Indications and Usage For the treatment and management of obesity.
Marketing Status Prescription; Discontinued
ATC Code A08AA01
DrugBank ID DB00191
KEGG ID D05458
MeSH ID D010645
PubChem ID 4771
TTD Drug ID D0U0RZ
NDC Product Code Not Available
Synonyms Phentermine | Duromine | Phentermine Hydrochloride | Hydrochloride, Phentermine | Adipex-P | Adipex P | AdipexP | Ionamine
Chemical Information
Molecular Formula C10H15N
CAS Registry Number 122-09-8
SMILES CC(C)(CC1=CC=CC=C1)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dependence19.07.02.003--Not Available
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Diarrhoea haemorrhagic24.07.02.004; 07.02.01.0020.000494%Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.0040.000987%
Drug abuse19.07.02.0100.000451%Not Available
Dry mouth07.06.01.0020.000494%
Dysarthria19.19.03.001; 17.02.08.0010.000740%
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Dysphoria19.04.02.004--Not Available
Dyspnoea02.01.03.002; 22.02.01.0040.002221%
Dyspnoea exertional22.02.01.005; 02.01.03.003--Not Available
Euphoric mood19.04.02.006--
Eye haemorrhage24.07.05.002; 06.07.02.0010.001728%Not Available
Eye pain06.08.03.0020.001728%
Fatigue08.01.01.0020.002715%
Fear19.06.03.0010.000494%Not Available
Feeling cold08.01.09.0080.001974%Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Generalised tonic-clonic seizure17.12.01.0020.000494%Not Available
Glycosylated haemoglobin increased13.02.02.0050.000494%Not Available
Haematemesis24.07.02.011; 07.12.02.0020.001481%Not Available
Hallucination19.10.02.0020.001728%
Headache17.14.01.0010.004936%
Heart rate increased13.14.04.0020.000740%Not Available
Hemiparesis17.01.04.0010.000740%
Hyperhidrosis23.02.03.004; 08.01.03.0280.000987%
Hypertension24.08.02.0010.004442%
Hypoaesthesia17.02.06.0230.000494%Not Available
The 2th Page    First    Pre   2 3 4 5    Next   Last    Total 5 Pages